Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.

Confavreux, C B; Chapurlat, R D

Confavreux, C B; Chapurlat, R D.

Affiliation

Confavreux CB; Department of Rheumatology, INSERM U831-Université de Lyon, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon 69003, France. cyril.confavreux@inserm.fr

Osteoporos Int ; 22(4): 1023-36, 2011 Apr.

Article in En | MEDLINE | ID: mdl-20959960

Subject(s)

Antirheumatic Agents/therapeutic use; Arthritis, Rheumatoid/drug therapy; Biological Products/therapeutic use; Osteoporosis/prevention & control; Spondylitis, Ankylosing/drug therapy; Arthritis, Rheumatoid/complications; Cytokines/antagonists & inhibitors; Humans; Osteoporosis/etiology; Spondylitis, Ankylosing/complications

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Arthritis, Rheumatoid / Spondylitis, Ankylosing / Biological Products / Antirheumatic Agents Type of study: Etiology_studies Limits: Humans Language: En Journal: Osteoporos Int Journal subject: METABOLISMO / ORTOPEDIA Year: 2011 Type: Article Affiliation country: France

Fulltext

XML

PubMed Links

Search on Google